|
1
|
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.
|
Leukemia
|
2007
|
2.96
|
|
2
|
Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells.
|
Blood
|
1998
|
1.93
|
|
3
|
Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species.
|
Blood
|
2001
|
1.51
|
|
4
|
Bone marrow assessment in B-cell chronic lymphocytic leukaemia: aspirate or biopsy? A comparative study in 258 patients.
|
Br J Haematol
|
1996
|
1.44
|
|
5
|
Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: a report of 12 patients from a single institution.
|
Ann Oncol
|
1998
|
1.37
|
|
6
|
PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.
|
Blood
|
1994
|
1.36
|
|
7
|
Harms and benefits of lymphocyte subpopulations in patients with acute stroke.
|
Neuroscience
|
2008
|
1.24
|
|
8
|
Central nervous system involvement in mantle cell lymphoma.
|
Ann Oncol
|
2007
|
1.22
|
|
9
|
The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
|
Ann Oncol
|
2006
|
1.18
|
|
10
|
Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
|
Leukemia
|
2003
|
1.17
|
|
11
|
Enumeration of CD4(+) T-cells in the peripheral blood of HIV-infected patients: an interlaboratory study of the FACSCount system.
|
Cytometry
|
1999
|
1.16
|
|
12
|
Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL.
|
Leukemia
|
2012
|
1.14
|
|
13
|
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].
|
Leukemia
|
2006
|
1.13
|
|
14
|
In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia.
|
Blood
|
1999
|
1.11
|
|
15
|
[Splenic lymphoma with circulating villous lymphocytes. Study of 6 patients].
|
Sangre (Barc)
|
1993
|
1.08
|
|
16
|
BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.
|
Leukemia
|
2008
|
1.06
|
|
17
|
Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status.
|
Leukemia
|
2001
|
1.01
|
|
18
|
Comparison of four prognostic scores in peripheral T-cell lymphoma.
|
Ann Oncol
|
2010
|
0.99
|
|
19
|
Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells.
|
Leukemia
|
2005
|
0.95
|
|
20
|
Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive features.
|
J Clin Oncol
|
1999
|
0.93
|
|
21
|
Acute lymphoid leukemia following polycythemia vera.
|
Leuk Lymphoma
|
1999
|
0.87
|
|
22
|
Sorafenib targets BCR kinases and blocks migratory and microenvironmental survival signals in CLL cells.
|
Leukemia
|
2011
|
0.87
|
|
23
|
FISH analysis for BCL-1 rearrangements and trisomy 12 helps the diagnosis of atypical B cell leukaemias.
|
Leukemia
|
1999
|
0.86
|
|
24
|
Cutaneous involvement as the first manifestation in a case of T-cell prolymphocytic leukaemia.
|
Acta Derm Venereol
|
1998
|
0.85
|
|
25
|
Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9.
|
Blood
|
2001
|
0.84
|
|
26
|
Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia.
|
Br J Haematol
|
1990
|
0.84
|
|
27
|
Identification of a natural soluble form of human CD5.
|
Tissue Antigens
|
1999
|
0.83
|
|
28
|
Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?
|
Leukemia
|
2002
|
0.82
|
|
29
|
Frequent somatic mutations in components of the RNA processing machinery in chronic lymphocytic leukemia.
|
Leukemia
|
2012
|
0.82
|
|
30
|
Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size.
|
Leuk Res
|
2010
|
0.81
|
|
31
|
Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients.
|
Leuk Res
|
2005
|
0.81
|
|
32
|
B-type large-cell primary splenic lymphoma with massive involvement of the red pulp.
|
Acta Haematol
|
1993
|
0.80
|
|
33
|
Expression of the adhesion molecule ICAM-1 in non-Hodgkin's lymphoma: relationship with tumor dissemination and prognostic importance.
|
J Clin Oncol
|
1998
|
0.79
|
|
34
|
Central nervous system involvement in acute promyelocytic leukemia. A description of two cases and review of the literature.
|
Haematologica
|
1999
|
0.78
|
|
35
|
Isolation and characterisation of a CDw50 negative Jurkat T-cell line variant (PPL.1).
|
Leuk Res
|
1993
|
0.78
|
|
36
|
A variant of Glanzmann's thrombasthenia which fails to express a GPIIb-IIIa related epitope that is recognized by a specific monoclonal antibody (C17).
|
Br J Haematol
|
1992
|
0.77
|
|
37
|
Ristocetin induces platelet aggregation: a morphological demonstration.
|
Br J Haematol
|
1988
|
0.77
|
|
38
|
Bladder involvement of diffuse large B-cell lymphoma diagnosed by a cytological study of the urine.
|
Leuk Lymphoma
|
2002
|
0.77
|
|
39
|
alpha Interferon in chronic lymphocytic leukaemia.
|
Eur J Cancer
|
1991
|
0.76
|
|
40
|
Assessment of peripheral blood lymphocyte subsets in idiopathic myelofibrosis.
|
Eur J Haematol
|
2000
|
0.76
|
|
41
|
Myelomonocytic antigens in B-cell chronic lymphocytic leukemia.
|
Leuk Res
|
1995
|
0.76
|
|
42
|
Phenotypic changes in neutrophil granulocytes after G-CSF administration in patients with acute lymphoblastic leukemia under chemotherapy.
|
Haematologica
|
1998
|
0.76
|
|
43
|
Reticulated platelets in uremic patients: effect of hemodialysis and continuous ambulatory peritoneal dialysis.
|
Am J Hematol
|
1995
|
0.76
|
|
44
|
[T lymphoblastic leukemia with leukemoid reaction or the extramedullary blast crisis of Philadelphia chromosome-negative chronic myeloid leukemia? Comments apropos 2 cases].
|
Med Clin (Barc)
|
1990
|
0.76
|
|
45
|
Treatment of early stage-B chronic lymphocytic leukemia with alpha-2b interferon after chlorambucil reduction of the tumoral mass.
|
Ann Hematol
|
1991
|
0.76
|
|
46
|
'Lymphoid' blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features.
|
Br J Haematol
|
1998
|
0.75
|
|
47
|
Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
|
Clin Lymphoma
|
2001
|
0.75
|
|
48
|
[Neuropathy of the brachial plexus in a patient with acute promyelocytic leukemia].
|
Rev Clin Esp
|
1988
|
0.75
|
|
49
|
[Intense neutropenia of 14 years duration as the only manifestation of a myelodysplastic syndrome].
|
Med Clin (Barc)
|
1995
|
0.75
|
|
50
|
[Evaluation of the Sysmex NE-8000 analyzer according to the norms of the International Committee for Standardization in Hematology].
|
Sangre (Barc)
|
1991
|
0.75
|
|
51
|
Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.
|
Leukemia
|
1993
|
0.75
|
|
52
|
[Effect of treatment with recombinant interferon alfa on natural killer activity in patients with chronic type B lymphatic leukemia].
|
Sangre (Barc)
|
1989
|
0.75
|
|
53
|
Ph-positive chronic myeloid leukemia mimicking essential thrombocythemia and terminating into megakaryoblastic blast crisis: report of two cases with molecular studies.
|
Leukemia
|
1993
|
0.75
|
|
54
|
Lymphocyte activation and proliferation markers in the material obtained by fine needle aspiration cytology.
|
Transplant Proc
|
1992
|
0.75
|
|
55
|
[Evaluation of the reproducibility of automated monocyte counting using flow cytometry and monoclonal antibodies].
|
Sangre (Barc)
|
1994
|
0.75
|
|
56
|
[Initial evaluation of the Technicon H*2 blood analyzer: speed and quality of results].
|
Sangre (Barc)
|
1990
|
0.75
|
|
57
|
[Abnormal drainage of the pulmonary vessels in a patient with Fanconi's aplasia].
|
Sangre (Barc)
|
1988
|
0.75
|
|
58
|
Phenotypic analysis of blood neutrophils in a patient with chronic idiopathic neutropenia and favorable response to G-CSF treatment.
|
Am J Hematol
|
1996
|
0.75
|
|
59
|
CD11c positive B-chronic lymphocytic leukemia.
|
Blood
|
1991
|
0.75
|
|
60
|
Granular lymphocyte proliferative disorders: a multicenter study of 20 cases.
|
Ann Hematol
|
1994
|
0.75
|
|
61
|
Platelet activation during hemodialysis measured through exposure of p-selectin: analysis by flow cytometric and ultrastructural techniques.
|
J Lab Clin Med
|
1994
|
0.75
|
|
62
|
Giant parallel tube arrays (PTAs), a new type of lymphocyte inclusion.
|
Leukemia
|
1994
|
0.75
|
|
63
|
Hypertriglyceridemia in bone marrow transplant recipients: another side effect of cyclosporine A.
|
Bone Marrow Transplant
|
1989
|
0.75
|
|
64
|
[Evaluation of the Coulter MAXM. Differential leukocyte count and left-shift alarm].
|
Sangre (Barc)
|
1997
|
0.75
|
|
65
|
[Meningeal infiltration in multiple myeloma. Study of a new case and literature review].
|
Rev Clin Esp
|
1992
|
0.75
|
|
66
|
CD56 expression could be associated with monocytic differentiation in acute myeloid leukemia with t(8;21).
|
Haematologica
|
2001
|
0.75
|
|
67
|
The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
|
Br J Haematol
|
1992
|
0.75
|
|
68
|
Immunophenotypic and ultrastructural study in peripheral blood neutrophil granulocytes following bone marrow transplantation.
|
Br J Haematol
|
1997
|
0.75
|
|
69
|
[Non-cardiogenic pulmonary edema after administration of amphotericin B].
|
Med Clin (Barc)
|
1988
|
0.75
|